Hers vs Noom Med: Which GLP-1 Provider Is Better?
Short answer: Noom Med scores higher on our rubric, 7.4/10 against 7.3/10. Full reasoning, pricing and the cases where the other one wins are below.
Noom Med beats Hers overall, scoring 7.4/10 vs 7.3/10. Published pricing is not a like-for-like monthly comparison: Hers is $188 first month, then $298/mo; Noom Med is $79 first month, then $199/mo. Choose Hers for women who want a female-focused platform and can budget at least $188 initially and $298/mo ongoing for a $149 medication path. Choose Noom Med for users who want a low-dose glp-1 with biomarker monitoring and can absorb the step from a $79 starter to $199/mo ongoing.
A side-by-side look at Hers and Noom Med to help you decide. We compare them on:
- •Starting price per month
- •Our overall score, out of 10
- •Medication type, brand-name or compounded
- •Whether they accept insurance
- •Who each one is best for
Hers
#30 of 54The women's health arm of Hims & Hers Health (NYSE: HIMS). Hers lists Wegovy pill, Foundayo, and Ozempic pill medication from $149, a Wegovy pen from $199, Zepbound from $299, and compounded options. A required Weight Loss Membership adds $39 in month one and $149/mo thereafter, so the all-in floor for a $149 medication path is $188 initially and $298/mo ongoing; exact product and dose prices vary.
Visit HersNoom Med
#23 of 54Noom restructured Noom Med in 2026 into a GLP-1 ladder plus a non-GLP-1 pill: Microdose GLP-1Rx at $79 then $199/mo, GLP-1Rx at $129 then $249/mo, GLP-1Rx Plus at $149 then $299/mo, and a metformin pill at $69 then $99/mo that is not a GLP-1. Verified 2026-07-27. Historic note: the Full GLP-1Rx program ($149 intro → $349/mo on 12-week subscription). Coaching app included at every tier.
Visit Noom Med| Feature | Hers | Noom Med |
|---|---|---|
| Why each one | A major women-focused telehealth platform with a direct Novo Nordisk partnership (Wegovy pill from $149 and pen from $199 before required membership) and a Lilly partnership (Zepbound medication from $299) alongside compounded options. | The only GLP-1 platform built on a decade of behavioral psychology research, combining medication with Noom's proven coaching methodology for lasting habit change. |
| Our Score | 7.3/10 | 7.4/10 |
| Headline Price | $188 first month, then $298/mo | $79 first month, then $199/mo |
| Medication Type | Both | Both |
| Insurance Accepted | No | Yes |
| Best For | Women who want a female-focused platform and can budget at least $188 initially and $298/mo ongoing for a $149 medication path | Users who want a low-dose GLP-1 with biomarker monitoring and can absorb the step from a $79 starter to $199/mo ongoing |
| Watch out for | Pending federal enforcement action against the parent company. On July 29, 2026 the FTC, joined by Utah and California acting through Los Angeles County Counsel, filed a complaint against Hims & Hers Health, Inc. in the U.S. District Court for the Northern District of California, alleging violations of the FTC Act and the Restore Online Shoppers' Confidence Act over subscription billing, cancellation friction, and sharing consumer health information with advertising platforms. Case status is Pending. These are allegations, not findings. | Tiered pricing is genuinely confusing, and the cheapest advertised tier ($69 then $99/mo) is metformin rather than a GLP-1, which is easy to mistake for the GLP-1 entry price [Verified 2026-07-27] |
| Ranking | #30 | #23 |
| Get started | Visit Hers | Visit Noom Med |
Pros & Cons Compared
Hers
Pros
- +FDA-approved brand paths include Wegovy pill, Foundayo, and Ozempic pill medication from $149 and a Wegovy pen from $199; with the required membership, a $149 medication path totals $188 initially and $298/mo ongoing
- +Zepbound access via the Lilly/Hims-Hers partnership announced 2026
- +Publicly traded company (NYSE: HIMS) with strong financial backing and regulatory compliance
- +Broader women's health platform, integrates weight loss with hormonal, skin, and wellness services
Cons
- −Pending federal enforcement action against the parent company. On July 29, 2026 the FTC, joined by Utah and California acting through Los Angeles County Counsel, filed a complaint against Hims & Hers Health, Inc. in the U.S. District Court for the Northern District of California, alleging violations of the FTC Act and the Restore Online Shoppers' Confidence Act over subscription billing, cancellation friction, and sharing consumer health information with advertising platforms. Case status is Pending. These are allegations, not findings.
- −Every medication figure excludes the required Weight Loss Membership ($39 first month, then $149/mo); exact product and dose prices can increase the total above the $188/$298 floor
- −Support runs at big-platform scale, fine for routine refills, less personal if you want high-touch care
- −Compounded pricing starts at $199/mo with stepped pricing at higher doses, budget for the dose you'll end up on, not the entry dose
- −Zepbound medication starts at $299 before the required membership; that path totals $338 in month one and at least $448/mo ongoing, with exact dose pricing potentially higher
Noom Med
Pros
- +Tiered 2026 entry, $69/mo branded telehealth tier lets users start with just medication access and the coaching app
- +Microdose GLP-1Rx is $79 for the first 4 weeks then $199/mo billed quarterly, low-dose GLP-1 plus biomarker monitoring for side-effect-sensitive users [Verified 2026-07-27]
- +Insurance accepted for qualifying plans, can significantly reduce out-of-pocket costs on brand-name meds
- +Industry-leading behavioral coaching app with years of psychology-based weight loss methodology
Cons
- −Tiered pricing is genuinely confusing, and the cheapest advertised tier ($69 then $99/mo) is metformin rather than a GLP-1, which is easy to mistake for the GLP-1 entry price [Verified 2026-07-27]
- −Full GLP-1Rx program requires 12-week subscription ($149 intro rate applies only for the first few weeks)
- −Medication costs on the $69 tier are out-of-pocket, the low tier price is just the platform
- −App coaching still requires real engagement, skip-prone users waste the behavioral value
Our Verdict
Noom Med edges out Hers with a score of 7.4/10 vs 7.3/10. Published pricing is not a like-for-like monthly comparison: Hers is $188 first month, then $298/mo; Noom Med is $79 first month, then $199/mo. Noom Med accepts insurance, which can significantly reduce your out-of-pocket costs.
Read Full Reviews
Related comparisons
More head-to-head comparisons involving Hers and Noom Med.
Not comparing, just asking? Quick answers to the most-asked GLP-1 questions →
- Hers vs Elevate Healthfrom $233/mo
- Hers vs Zealthyfrom $286/mo
- Hers vs Lemonaid Healthpublished $129/mo; total not verified
- Noom Med vs Strut Healthfrom $99/mo
- Noom Med vs Embodyfrom $69/mo
- Noom Med vs PeterMDfrom $165/mo
Not sure which one is right for you?
Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.
Our pick of these two: Noom Med · 7.4/10